NASDAQ · Financial Services · Asset Management
Generate Biomedicines, Inc.
GENB
Generate Biomedicines, Inc. CEO Michael T. Nally · Market cap $2.1B.
$16.59
+1.10 · +7.13%
52w hi $16.6952w lo $11.00
Off 52w high 16.4%
71
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 04 | Michael Nally | Chief Executive Officer | Buy | 20,000 | $12.00 | +$240K | 51 |
| Mar 02 | AFEYAN NOUBAR | Buy | 1,562,500 | $16.00 | +$25.00M | 71 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay